“…Although strong relationships between specific variants or clades in SARS-CoV-2 and the clinical outcome have not been identified (Grubaugh, Hanage, & Rasmussen, 2020;Hodcroft et al, 2020;van Dorp et al, 2020), different relevant parameters could be impacted by mutations in the virus genome. These include transmissibility, severity, clinical management, mortality, vaccines as well as the performance of molecular tests for diagnosis (Hodcroft et al, 2020;Koyama, Platt, & Parida, 2020;Teng, Sobitan, Rhoades, Liu, & Tang, 2020). Until now, genetic factors and, more importantly, comorbidities of the host seem to have the predominant impact on the fate of COVID-19 patients (LoPresti, Beck, Duggal, Cummings, & Solomon, 2020;Sironi et al, 2020;Toyoshima, Nemoto, Matsumoto, Nakamura, & Kiyotani, 2020).…”